ARCHIVES

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

This article is from The Cancer Letter archive.

Vol. 40 No. 16 | April 18, 2014

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

Sharp To Direct New Institute For Brain Research At MIT.

March 3, 2000

Clinical Trials Approved By NCI

March 26, 2004

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987